Contraception
Volume 73, Issue 5 , Pages 437-439 , May 2006

Reproductive health risks in perspective

Received 16 January 2006 ,Revised 17 January 2006 ,Accepted 18 January 2006.

References 

  1. Laudan L. The book of risks. New York: John Wiley and Sons; 1994;
  2. Schwingl PJ, Ory HW, Visness CM. Estimates of the risk of cardiovascular death attributable to low-dose oral contraceptives in the United States. Am J Obstet Gynecol. 1999;180:241–249
  3. Escobedo LG, Peterson HB, Grubb GS, Franks AL. Case-fatality rates for tubal sterilization in U.S. hospitals, 1979–1980. Am J Obstet Gynecol. 1989;160:147–150
  4. Hajjeh RA, Reingold A, Weil A, Shutt K, Schuhat A, Perkins BA. Toxic shock syndrome in the United States, 1979–1996. Emerg Infect Dis. 1999;5:807–810
  5. U.S. Bureau of the Census . Statistical abstract of the United States: 2003. Washington (DC): Government Printing Office; 2003;[Table 11]
  6. Berg CJ, Chang J, Callaghan WM, Whitehead SJ. Pregnancy-related mortality in the United States, 1991–1997. Obstet Gynecol. 2003;101:289–296
  7. Saraiya M, Green CA, Berg CJ, Hopkins FW, Koonin LM, Atrash HK. Spontaneous abortion-related deaths among women in the United States — 1981–1991. Obstet Gynecol. 1999;94:172–176
  8. Personal communication from Danco Laboratories, C Summers. 9 March 2006.
  9. Bartlett LA, Berg CJ, Shulman HB, et al. Risk factors for legal induced abortion-related mortality in the United States. Obstet Gynecol. 2004;103:729–737
  10. Burkman R, Schlesselman JJ, Zieman M. Safety concerns and health benefits associated with oral contraception. Am J Obstet Gynecol. 2004;190(Suppl):S5–S22
  11. Marchbanks PA, McDonald HG, Wilson HG, et al. Oral contraceptives and the risk of breast cancer. N Engl J Med. 2002;346:2025–2032
  12. Smith JS, Green J, Berrington de Gonzalez A, et al. Cervical cancer and use of hormonal contraceptives: a systematic review. Lancet. 2003;361:1159–1167
  13. Collaborative Group on Hormonal Factors in Breast Cancer . Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53,297 women with breast cancer and 100,239 women without breast cancer from 54 epidemiological studies. Lancet. 1996;347:1713–1727
  14. Ortho-McNeil Pharmaceutical. Ortho Evra Product labeling. Revised November 2005.
  15. Media report on Ortho Evra patch sets off safety concerns in women. Contracept Technol Update. 2005;26:113–115

 This editorial is adapted from Trussell J, Choosing a contraceptive: efficacy, safety, and personal considerations, in Hatcher RA, Trussell J, Nelson A et al., Contraceptive Technology: Nineteenth Revised Edition. New York NY: Ardent Media, 2006 (in press), with the permission of Contraceptive Technology Communications.

PII: S0010-7824(06)00035-7

doi: 10.1016/j.contraception.2006.01.008

Contraception
Volume 73, Issue 5 , Pages 437-439 , May 2006

Article Tools